Wellington Management Group LLP Roivant Sciences Ltd. Transaction History

Wellington Management Group LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$9.87 - $11.8 $696,999 - $833,292	70,618 New	70,618 $744,000
Q4 2023 Feb 12, 2024	BUY	$8.38 - $11.58 $114 Million - $158 Million	13,640,416 New	13,640,416 $153 Million
Q3 2023 Nov 14, 2023	SELL	$9.76 - $13.19 $3.45 Million - $4.66 Million	-353,579 Reduced 2.33%	14,842,976 $173 Million
Q2 2023 Aug 14, 2023	BUY	$7.09 - $10.08 $22.5 Million - $31.9 Million	3,167,758 Added 26.33%	15,196,555 $153 Million
Q1 2023 May 12, 2023	BUY	$6.92 - $9.98 $83.2 Million - $120 Million	12,028,797 New	12,028,797 $88.8 Million

311

508M

1.26M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.83B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.